Navigation Links
Building Biotech Technology Transfer Opportunities: Sponsor and Developer Strategies for Success
Date:7/7/2010

NEW YORK, July 7 /PRNewswire/ -- Reportlinker.com announces that a new market research report is available in its catalogue:

Building Biotech Technology Transfer Opportunities: Sponsor and developer strategies for success

http://www.reportlinker.com/p0185305/Building-Biotech-Technology-Transfer-Opportunities-Sponsor-and-developer-strategies-for-success.html?d=CPDAIN11

Drug developers have long been under pressure to introduce new products in an environment of escalating R&D costs, blockbuster patent expiration and resulting generic competition. Current weak economic conditions have exacerbated these challenges with sweeping R&D staff and budget reductions. In order to remain competitive, drug makers must now do more with less. Technology transfer, particularly of new biotechnologies that offer novel means to address unmet medical needs, offer a way to cost effectively address these challenges. They also provide technology developers with a mechanism to monetize their inventions.

However, while some drug m
'/>"/>

SOURCE Reportlinker
Copyright©2010 PR Newswire.
All rights reserved

Page: 1 2 3 4 5 6 7 8 9 10

Related biology technology :

1. PointCross Releases Catalyst for Building Business-Ready SharePoint Solutions in 1/10th the Time
2. Photo-catalytic, self cleaning coating for building exteriors
3. Techstreet Launches BuildingBlocks Utility for Industry Standards Saving Time and Increasing Productivity for Engineers
4. Arts Way Manufacturing Announces Launch of New Web Site For Arts Way Scientific - Buildings For Science
5. Secret of sandcastle construction could help revive ancient building technique, researchers say
6. Building better bone replacements with bacteria
7. Hendrick Construction Renovates USC Science Building
8. RPJ Housings Rebuilding Together Event Brings Estimated $300,000 Worth Of Volunteer Labor to Northern VA
9. InNexus Biotechnology Announces Launch of Large Scale Primate Study of DXL625
10. Yongye Biotechnology International Retains CCG Investor Relations
11. ThirdBiotech Announces Kemeta as Newest Sponsor
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:6/2/2015)... June 02, 2015 Cirrascale ... blade-based and rackmount computing and storage infrastructure for ... launch of its high density scale-out, two-in-one video ... Slipstream™ RM1622D . The high density, two-in-one system ... product family with Intel® Iris™ Pro graphics P6300 ...
(Date:6/2/2015)... NEWTOWN, Pa. , June 2, 2015   ... services and technology provider, today announced that David ... has been named Executive Vice President and Chief Financial ... 8, 2015. Peters brings more than 25 ... in pharmaceutical services. "David has extensive and deep knowledge ...
(Date:6/2/2015)... KONG , June 2, 2015 /PRNewswire/ -- China Cord Blood ... and "our"), China,s leading provider of ... stem cell storage services, today announced that the Special Committee ... appointed Houlihan Lokey ( China ) ... & Hamilton LLP as its United States ...
(Date:6/2/2015)... 2, 2015 MGB Biopharma ... resistance problem  MGB Biopharma, a biopharmaceutical ... to address the major global problem of antibiotic ... stable intravenous (IV) formulation of MGB-BP-3, designed for the ... The intravenous formulation of MGB-BP-3 is ...
Breaking Biology Technology:Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 2Cirrascale® Announces Support for Intel® Xeon® Processor E3-1200 v4 Product Family; Launches Server Offering Optimized for Low Cost-per-Stream Transcoding Applications 3BioClinica Names David Peters New Chief Financial Officer 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 2China Cord Blood Corporation's Special Committee Appoints Independent Financial Advisor and Legal Counsel to Evaluate Non-binding "Going Private" Proposal 3MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 2MGB Biopharma Succeeds in Developing an IV Formulation of MGB-BP-3 for the Treatment of Systemic Susceptible and Resistant Gram-Positive Hospital-Acquired Infections 3
... Schering-Plough Corporation (NYSE: SGP ) today ... in Japan, has received marketing approval for REMERON(R) ... major depressive disorder.(1) The product was developed jointly ... Meiji Seika will market the product under the ...
... US Oncology, Inc . today announced that ... pharmacy service, has exceeded the $15 million mark and has assisted ... since the launch of Care Advantage in August 2006. , ... as a positive resource to help so many cancer patients obtain ...
... SHANGHAI, July 9 /PRNewswire-Asia/ -- ... of ShangPharma Corporation, today,announces that it has expanded ... first biopharmaceutical company dedicated to the,development of novel ... will provide integrated services in the areas of ...
Cached Biology Technology:REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 2REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 3REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 4REMERON(R) Now Approved in Japan for the Treatment of Depression in Adult Patients 5OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 2OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 3OncologyRx Care Advantage(TM) Specialty Pharmacy Passes $15 Million Milestone in Patient Financial Assistance 4Shanghai ChemPartner and Agios Expand Integrated Drug Discovery Research Collaboration 2
(Date:5/25/2015)... 25, 2015  Australia,s market for wearable technologies is ... saw the advent of several trials and prototypes. The ... is expected to ignite interest in wearables as well ... Australia . This in turn will spur greater ... new partnerships amongst vendors and distributors. ...
(Date:5/20/2015)... May 20, 2015 ... has announced the addition of the  ... Iris Recognition Market"  report to their ... research service analyses trends in the ... and commercial sectors, globally. Despite hardware ...
(Date:5/18/2015)... Fingerprint Cards (FPC) has received an order for ... from one if its module partners. Deliveries are planned to ... the sensors will be used by smartphone manufacturers in ... amount to 740 MSEK to date. In addition to previously ... number of smaller orders not separately communicated amounting to more ...
Breaking Biology News(10 mins):Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 2Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 3Australian wearables market to grow at CAGR of 78%; revenue of A$1 billion by 2018, says Frost & Sullivan 4Global Iris Recognition Market Report 2015 - 5-Year Opportunity Analysis 2Fingerprint Cards Receives Touch Fingerprint Sensor Order of SEK 230 Million and Raises Revenue Guidance for 2015 2
... a species classified as vulnerable and at risk of extinction, ... or more. However, the youngest tortoises are more vulnerable, and ... study by Spanish researchers, who analysed the impact of a ... in Murcia (Spain) on these reptiles. "Tortoises can ...
... common form of malignancy in adult Caucasian populations, with more ... alone. Lifestyle risk factors but , ... to the aging structure of Western populations, and as a ... high sun exposure, which is a key risk factor for ...
... fisheries could pose a more serious threat to marine ... of Exeter, published today (19 July) in the British ... that tens of thousands of turtles from across the ... fisheries. Focusing on fisheries in Peru, the study ...
Cached Biology News:Tortoise populations can withstand fires every 30 years 2Some cutaneous HPV types may be involved in non-melanoma skin cancer development 2Study shows small-scale fisheries' impact on marine life 2
Acetyl CoA Carboxylase Antibody...
Anti-Human IFN-Gamma Receptor Chain 2 (beta chain) [CD119], Rabbit serum, NON-neutralizing polyclonal antibody...
AANAT [Arylalkylamine N-acetyltransferase; EC 2.3.1.87]...
Rac1/2/3 (L129) Antibody Shipping Temperature: HOT Storage Temperature: -20C...
Biology Products: